155 related articles for article (PubMed ID: 9300661)
41. Decreased frequency of HLA-DRB1 13 alleles in Frenchwomen with HPV-positive carcinoma of the cervix.
Sastre-Garau X; Loste MN; Vincent-Salomon A; Favre M; Mouret E; de la Rochefordiere A; Durand JC; Tartour E; Lepage V; Charron D
Int J Cancer; 1996 Jun; 69(3):159-64. PubMed ID: 8682580
[TBL] [Abstract][Full Text] [Related]
42. Association of HLA class II alleles with hepatitis C virus clearance and persistence in thalassemia patients from Iran.
Samimi-Rad K; Sadeghi F; Amirzargar A; Eshraghian MR; Alavian SM; Rahimnia R
J Med Virol; 2015 Sep; 87(9):1565-72. PubMed ID: 25970464
[TBL] [Abstract][Full Text] [Related]
43. Association between HLA class II gene and susceptibility or resistance to chronic hepatitis B.
Jiang YG; Wang YM; Liu TH; Liu J
World J Gastroenterol; 2003 Oct; 9(10):2221-5. PubMed ID: 14562382
[TBL] [Abstract][Full Text] [Related]
44. Opposing effects of the HLA-DRB1*0301-DQB1*0201 haplotype on the risk for multiple sclerosis in diverse Arab populations in Israel.
Benedek G; Paperna T; Avidan N; Lejbkowicz I; Oksenberg JR; Wang J; Brautbar C; Israel S; Miller A;
Genes Immun; 2010 Jul; 11(5):423-31. PubMed ID: 20463743
[TBL] [Abstract][Full Text] [Related]
45. Association of a CA repeat polymorphism upstream of the Fas ligand gene with multiple sclerosis.
Zayas MD; Lucas M; Solano F; Fernández-Pérez MJ; Izquierdo G
J Neuroimmunol; 2001 Jun; 116(2):238-41. PubMed ID: 11438180
[TBL] [Abstract][Full Text] [Related]
46. The immunogenetics of multiple sclerosis.
Svejgaard A
Immunogenetics; 2008 Jun; 60(6):275-86. PubMed ID: 18461312
[TBL] [Abstract][Full Text] [Related]
47. Identical HLA class II alleles predispose to drug-triggered and idiopathic pemphigus vulgaris.
Matzner Y; Erlich HA; Brautbar C; Sanilevitch A; Landau M; Brenner S; Friedmann A
Acta Derm Venereol; 1995 Jan; 75(1):12-4. PubMed ID: 7747528
[TBL] [Abstract][Full Text] [Related]
48. Peripheral blood cell bulk cultures are not suitable for the analysis of the genetic control of T-cell cytokine function.
Zipp F; Windemuth C; Dichgans J; Wienker T; Martin R; Müller C
Immunol Lett; 2001 Aug; 78(1):21-7. PubMed ID: 11470147
[TBL] [Abstract][Full Text] [Related]
49. Distribution of HLA-Dw2 in optic neuritis and multiple sclerosis indicates heterogeneity.
Hillert J; Käll T; Olerup O; Söderström M
Acta Neurol Scand; 1996 Sep; 94(3):161-6. PubMed ID: 8899048
[TBL] [Abstract][Full Text] [Related]
50. HLA associations in multiple sclerosis: implications for immunopathogenesis.
Vartdal F
Res Immunol; 1989 Feb; 140(2):192-6; discussion 245-8. PubMed ID: 2500681
[No Abstract] [Full Text] [Related]
51. Oligonucleotide dot-blot analysis of HLA-DQ beta alleles associated with multiple sclerosis.
Sinha AA; Bell RB; Steinman L; McDevitt HO
J Neuroimmunol; 1991 Apr; 32(1):61-5. PubMed ID: 2002091
[TBL] [Abstract][Full Text] [Related]
52. Potential role for the narcolepsy- and multiple sclerosis-associated HLA allele DQB1*0602 in schizophrenia subtypes.
Grosskopf A; Müller N; Malo A; Wank R
Schizophr Res; 1998 Mar; 30(2):187-9. PubMed ID: 9549784
[No Abstract] [Full Text] [Related]
53. Genetics of multiple sclerosis--how could disease-associated HLA-types contribute to pathogenesis?
Martin R
J Neural Transm Suppl; 1997; 49():177-94. PubMed ID: 9266427
[TBL] [Abstract][Full Text] [Related]
54. Gm allotypes in multiple sclerosis: influence susceptibility in HLA-DQwl-positive patients from the North-East of Scotland.
Francis DA; Brazier DM; Batchelor JR; McDonald WI; Downie AW; Hern JE
Clin Immunol Immunopathol; 1986 Dec; 41(3):409-16. PubMed ID: 3780055
[TBL] [Abstract][Full Text] [Related]
55. Multiple sclerosis and the HLA-D region: linkage and association studies.
Kellar-Wood HF; Wood NW; Holmans P; Clayton D; Robertson N; Compston DA
J Neuroimmunol; 1995 May; 58(2):183-90. PubMed ID: 7759607
[TBL] [Abstract][Full Text] [Related]
56. Custom CGH array profiling of copy number variations (CNVs) on chromosome 6p21.32 (HLA locus) in patients with venous malformations associated with multiple sclerosis.
Ferlini A; Bovolenta M; Neri M; Gualandi F; Balboni A; Yuryev A; Salvi F; Gemmati D; Liboni A; Zamboni P
BMC Med Genet; 2010 Apr; 11():64. PubMed ID: 20426824
[TBL] [Abstract][Full Text] [Related]
57. Genetics of multiple sclerosis: linkage and association studies.
Giordano M; D'Alfonso S; Momigliano-Richiardi P
Am J Pharmacogenomics; 2002; 2(1):37-58. PubMed ID: 12083953
[TBL] [Abstract][Full Text] [Related]
58. Familial multiple sclerosis in a Brazilian sample: Is HLA-DR15 involved in susceptibility to the disease?
da Silva Bernardes M; Antão Paiva CL; Ribeiro Paradela E; Papais Alvarenga M; Ferreira Pereira F; Vasconcelos CC; Papais Alvarenga RM
J Neuroimmunol; 2019 May; 330():74-80. PubMed ID: 30836273
[TBL] [Abstract][Full Text] [Related]
59. Effects of infectious mononucleosis and HLA-DRB1*15 in multiple sclerosis.
Ramagopalan SV; Sadovnick AD; Ebers GC; Giovannoni G
Mult Scler; 2010 Jan; 16(1):127-8. PubMed ID: 20051521
[No Abstract] [Full Text] [Related]
60. Multiple sclerosis, vitamin D, and HLA-DRB1*15.
Handunnetthi L; Ramagopalan SV; Ebers GC
Neurology; 2010 Jun; 74(23):1905-10. PubMed ID: 20530326
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
